CompletedNot Applicable

DNA Analysis of Tumor Tissue Samples From Young Patients With Acute Lymphoblastic Leukemia

United States520 participantsStarted 2004-05-13

Plain-language summary

This laboratory study is looking at DNA in tumor tissue samples from young patients with acute lymphoblastic leukemia. DNA analysis of tumor tissue may help doctors predict how well patients will respond to treatment

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Enrolled in clinical trial CCG-1891 or CCG-1952 with pediatric ALL

What they're measuring

Leukemia Relapse

Timeframe: Day 7

Development of veno-occlusive disease in patients on CCG-1952

Timeframe: Day 28

Development of a predictive model of leukemia relapse

Timeframe: Day 28

Development of a predictive model of leukemia toxicity

Timeframe: Day 28

Trial details

NCT IDNCT00897507

SponsorChildren's Oncology Group

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2016-05-05

View on ClinicalTrials.gov More Childhood Acute Lymphoblastic Leukemia in Remission trials